Sathlokhar Synergys E&C Global Crosses INR 400 Cr, Records 62 Percent YoY Growth

Chennai (Tamil Nadu) [India], May 12: Sathlokhar Synergys E&C Global Limited, a specialized EPC services provider, announced its Audited Financial Results for H2 FY25 & FY25.

Key Financial Highlights

H2 FY25 (Half Year)

  • Revenue: ₹25,749.08 Lakhs | YoY Growth: 28.38%
  • EBITDA: ₹3,659.05 Lakhs | YoY Growth: 20.72%
  • EBITDA Margin: 14.21% | YoY Change: -90.19 BPS
  • PAT: ₹2,632.05 Lakhs | YoY Growth: 18.28%
  • PAT Margin: 10.22% | YoY Change: -87.23 BPS
  • EPS: ₹10.90

FY25 (Full Year)

  • Revenue: ₹39,936.53 Lakhs | YoY Growth: 61.70%
  • EBITDA: ₹5,993.94 Lakhs | YoY Growth: 66.84%
  • EBITDA Margin: 15.01% | YoY Change: +46.18 BPS
  • PAT: ₹4,276.70 Lakhs | YoY Growth: 63.68%
  • PAT Margin: 10.71% | YoY Change: +12.94 BPS
  • EPS: ₹20.73

Reflecting on the company’s achievements in H2 FY25 & FY25, Mr. G. Thiyagu, Chairman MD & CEO of Sathlokhar Synergys E&C Global Limited expressed, “The second half of this financial year has been a transformative period for Sathlokhar Synergys. In FY25, the company achieved a remarkable 62.47% year-on-year increase in total income, reaching ₹40,182.69 lakhs. Our revenue from operations also increased by 61.70%, reaching ₹39,936.53 lakhs. EBITDA surged by 66.84% to ₹5,993.94 lakhs, while profit after tax rose by 63.68% to ₹4,276.70 lakhs, showcasing our unwavering commitment to operational excellence and sustained growth.

This success is a testament to the relentless dedication of our team and the confidence our clients place in us. With a robust order book and a significant portion already billed, we remain well-positioned to achieve our ambitious targets for the full fiscal year, with a strong pipeline of projects to be executed in the second half.

Our strategic focus on high growth sectors ranging from EPC turnkey solutions for industrial buildings, logistics parks, and commercial infrastructure to institutional projects, hospitals, hospitality, and renewable energy continues to open up new opportunities. At the same time, our financial stability enables us to pursue large scale, high value projects with confidence.

Sathlokhar Synergys has proactively expanded its market footprint by engaging with a broad network of potential clients and submitting high value proposals across key sectors. With a consistently strong conversion rate on new project bids, the company is well positioned to secure significant contracts that will drive the next phase of its growth and expansion.

Looking ahead, Sathlokhar Synergys remains steadfast in its mission to deliver best in class engineering and construction solutions that not only meet but consistently exceed client expectations. By prioritizing quality, operational efficiency, and sustainable development, the company is poised to play a transformative role in shaping the future of India’s infrastructure landscape.”

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More